Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ruben Montes de Oca
Observed names:
R Montes de Oca,
Ruben Montes De Oca,
Ruben Montes de
Institutions:
United States Food and Drug Administration,
Center for Tobacco Products
Observed institutions:
National Institutes of Health,
United States Food and Drug Administration,
Johns Hopkins University,
George Washington University,
National Institute of Allergy and Infectious Diseases,
Center for Tobacco Products,
Agency for Healthcare Research and Quality
show all 7
ORCID:
0009-0000-7494-4897
Observed ORCID:
0009-0000-7494-4897
OpenAlex ID:
A5109114849
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
2010
·
D. Rebecca Prevots
, Pamela A. Shaw
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
610
Hair Mercury Levels in U.S. Children and Women of Childbearing Age: Reference Range Data from NHANES 1999–2000
2004
·
Margaret A. McDowell
, Charles F. Dillon
, et al.
·
Environmental Health Perspectives
·
402
Trends and Burden of Bronchiectasis-Associated Hospitalizations in the United States, 1993-2006
2010
·
Amy E. Seitz
, Kenneth N. Olivier
, et al.
·
CHEST Journal
·
264
PDF
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
2007
·
Mark S Sulkowski
, Shruti H Mehta
, et al.
·
AIDS
·
207
Nontuberculous Mycobacteria–associated Lung Disease in Hospitalized Persons, United States, 1998–2005
2009
·
Megan E. Billinger
, Kenneth N. Olivier
, et al.
·
Emerging infectious diseases
·
156
PDF
Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution
2009
·
Ashwin Balagopal
, Stuart C Ray
, et al.
·
AIDS
·
76
U.S. medical resident familiarity with national tuberculosis guidelines
2007
·
Petros C Karakousis
, Frangiscos G Sifakis
, et al.
·
BMC Infectious Diseases
·
20
PDF
Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
6
PDF
Military Compensation: DOD Needs More Complete and Consistent Data to Assess the Costs and Policies of Relocating Personnel
2015
·
Brenda S Farrell
, Tom Gosling
, et al.
·
4
Electronic Nicotine Delivery Systems Use and Nicotine Exposure Among Adults Who Use ENDS Alone or With Cigarettes: The Population Assessment of Tobacco and Health Study 2013–2019
2025
·
Kathryn C Edwards
, Katherine Garcia-Rosales
, et al.
·
Nicotine & Tobacco Research
·
2
Prevalence of Nontuberculous Mycobacterial Disease, Kaiser Permanente Southern California, and Group Health Cooperative, Seattle, Washington, 1991-2006.
2009
·
DR Prevots
, D Strickland
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Prevalence of Bronchiectasis-Associated Hospitalizations: USA, 1993-2006.
2009
·
A Seitz
, K Oliver
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
Supplementary Table 2 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Table 1 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 3 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 5 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 7 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 6 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 2 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Data from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 4 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Data from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Supplementary Figure 1 from Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014)
2024
·
Cindy M. Chang
, Sapna Thakur
, et al.
Show more works
View as search
Works count:
23
Citation count:
1,750
H-index:
7
I10-index:
7
Year
Topic
Type